Skip to main content
Signal8

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

$CYTKPress releaseJun 17, 2026, 4:00 PM ETRead the release

Cytokinetics granted inducement awards to 12 new employees, including options to purchase 24,784 shares and 16,429 RSUs. The options have an exercise price of $71.38 per share and vest over four years, while RSUs vest over three years.

Key figures

Psus shares
2242
Rsus shares
16429
Options shares
24784
Option exercise price
71.38

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.